Seufferlein and coworkers analyzed the ctDNA and their corresponding tumor tissue DNA in a cohort of 20 PDAC patients by a targeted NGS and ddPCR gene panel (KRAS, TP53, SMAD4, CDKN2A, APC, ATM and FBXW7). The gene discussed is TP53; the disease is neoplasm.